No Data
No Data
Micro-tech (688029.SH): Shareholder Huakang reduced its shareholding percentage to 5%.
Micro-tech (688029.SH) announced that from July 25, 2024 to August 6, 2024, the company...
Micro-tech (688029.SH): Has repurchased 0.04% of its shares.
On August 1st, Gelunhui announced that as of July 31, 2024, the company has cumulatively repurchased 82,890 shares, accounting for 0.04% of the total share capital of the company. The highest purchase price was 62.74 yuan/share, the lowest was 58.30 yuan/share, and the total amount paid was 5,111,787.00 yuan (excluding stamp duty, transaction commission and other transaction costs).
Micro-tech (688029.SH): There is no production capacity in the USA, and there are no plans to produce in the USA at present.
Micro-Tech (688029.SH) stated on the interactive platform on July 31 that the company has no production capacity in the USA and has no plans to produce in the USA.
Micro-tech (688029.SH)'s subsidiary Kangyou Medical plans to increase capital and expand by implementing stock-based incentives for employees.
Micro-tech (688029.SH) announced that its subsidiary, Nanjing Kangyou Medical Technology Co., Ltd. (referred to as "..."
Micro-tech (688029.SH): first buyback of 0.03% shares involving 3.8878 million yuan.
On July 17th, Gelonhui reported that Micro-tech (688029.SH) bought back 62,090 shares of its own stock through the Shanghai Stock Exchange trading system using centralized bidding trading for the first time, accounting for 0.03% of the company's total share capital of 187,847,422 shares. The highest buyback price was 62.74 yuan/share, the lowest was 62.47 yuan/share, and the total amount paid was RMB 3,887,822.86 (excluding stamp duty, transaction commission and other trading fees). This share buyback complies with relevant laws and regulations.
Retail Investors Are Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥947m Last Week
No Data